▶︎ Journal of Atherosclerosis and Thrombosis
——————————
Reviews
——————————-
Emerging Roles of the Innate Immune System Regulated by DNA Sensors in the Development of Vascular and Metabolic Diseases
Daiju Fukuda, et al., J Atheroscler Thromb, 2022; 29: 297-307.
Crosstalk between Iron and Arteriosclerosis
Yoshiro Naito, et al., J Atheroscler Thromb, 2022; 29: 308-314.
——————————
Editorials
——————————-
Serotonin and Atheroscelotic Cardiovascular Disease
Michio Shimabukuro, J Atheroscler Thromb, 2022; 29: 315-316.
Can Upstroke Time be a More Significant Predictor for Cardiovascular Disease Than Ankle-Brachial Index?
Yasuyoshi Takei, J Atheroscler Thromb, 2022; 29: 317-319.
A Risk Prediction Model of Atherosclerotic Cardiovascular Disease in Japan
Isao Saito, J Atheroscler Thromb, 2022; 29: 320-321.
——————————
Original Articles
——————————
5-HT2A Receptor and 5-HT Degradation Play a Crucial Role in Atherosclerosis by Modulating Macrophage Foam Cell Formation, Vascular Endothelial Cell Inflammation, and Hepatic Steatosis
Yingying Ma, et al., J Atheroscler Thromb, 2022; 29: 322-336.
Usefulness of Upstroke Time per Cardiac Cycle for Cardiovascular and All-Cause Mortality Prediction in Patients with Normal Ankle-Brachial Index
Ho-Ming Su, et al., J Atheroscler Thromb, 2022; 29: 337-344.
Development and Validation of a Risk Prediction Model for Atherosclerotic Cardiovascular Disease in Japanese Adults: The Hisayama Study
Takanori Honda, et al., J Atheroscler Thromb, 2022; 29: 345-361.
Quantitative Validation of the Coronary Angioscopic Yellow Plaque with Lipid Core Burden Index Assessed by Intracoronary Near-Infrared Spectroscopy
Takashi Omatsu, et al., J Atheroscler Thromb, 2022; 29: 362-369.
Impact of Longer Hemodialysis Vintage with Higher Serum Phosphorus Level on Clinical Outcomes in Patients with Chronic Limb-Threatening Ischemia Presenting Tissue Loss after Endovascular Therapy
Naoko Higashino, et al., J Atheroscler Thromb, 2022; 29: 370-378.
Comparison of Endothelial Dysfunction in Coronary Arteries with Bare Metal and 2nd-Generation Drug-Eluting Stents
Yusuke Akiyama et al., J Atheroscler Thromb, 2022; 29: 379-392.
Recurrent Stroke Incidence and Etiology in Patients with Embolic Stroke of Undetermined Source and Other Stroke Subtypes
Sono Toi, et al., J Atheroscler Thromb, 2022; 29: 393-402.
Characterization of Salivary Microbiota in Patients with Atherosclerotic Cardiovascular Disease: A Case-Control Study
Nahoko Kato-Kogoe, et al., J Atheroscler Thromb, 2022; 29: 403-421.
Impact of Major Cardiovascular Risk Factors on the Incidence of Cardiovascular Disease among Overweight and Non-Overweight Individuals: The Circulatory Risk in Communities Study (CIRCS)
Takumi Matsumura, et al., J Atheroscler Thromb, 2022; 29: 422-437.